RNAZ (TransCode Therapeutics) FFO


RNAZ TransCode Therapeutics Inc RNAZ
34 GF Score
Price $4.84
! 1 Warning Sign
View Full Analysis

What is TransCode Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

RNAZ
34GF Score
TransCode Therapeutics Inc RNAZ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TransCode Therapeutics Business Description

Address 6 Liberty Square, No. 2382, Boston, MA, USA, 02109
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
34GF Score

Get the complete analysis for RNAZ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.84
Price